Pinsent Masons bolsters Munich office with double hire

02 May 2014 | 02:00 pm | 1 min. read

International law firm Pinsent Masons has strengthened its Munich office with the appointments of competition partner Michael Reich and corporate partner Tobias Rodehau.

Both Michael and Tobias join from German law firm Arqis. Michael, who specialises in competition law, will provide advice to German speaking clients on a range of contentious and non-contentious matters and support the firm's multijurisdictional team on pan-European antitrust cases.

Tobias specialises in corporate work, primarily in the area of technology-focused private equity and venture capital, for which he has a strong reputation in the Munich market. His expertise will add to the existing corporate team and boost the firm's offering in the technology investment field.

The appointments follow the arrival of tax specialist Werner Geisselmeier at the firm in December.

Commenting on their arrivals, David Ryan, managing partner at Pinsent Masons said:

"Our Munich office continues to exceed all our expectations and we are delighted to add Michael and Tobias to our team. We remain committed to making strategic investments in order to grow our international business in-line with our sector-focused strategy."

Ulrich Lohmann, partner and head of Pinsent Masons' Munich office, said:

"We are delighted that Michael and Tobias have agreed to join Pinsent Masons. Their arrival will strengthen Pinsent Masons' reputation in the German market - in the technology sector in particular - and mark another step in our journey toward becoming a law firm of truly international reach."

Pinsent Masons has also revealed that it is launching a global task force to target global work from German businesses operating internationally. The firm, which opened in Munich two years ago, now has an extensive network of German-qualified lawyers operating throughout its international offices.

Lohmann said:

“Something that has become increasingly clear over the past two years is that we amassed a remarkable number of fully qualified German Rechtsanwälte who are also dual qualified in their 'host' country. This network is proving extremely popular among our client base in Germany, Austria and Switzerland who are increasingly seeking advice on global issues linked to export, supply, distribution and purchasing of goods. This has meant more work around the acquisition of undertakings, entering into joint-ventures and establishment of subsidiaries and branches throughout the world."

The task force is being led by Björn Gehle, Head of the German desk in Dubai, Carsten Rumberg, Head of the German desk in London, Ulrich Lohmann, Head of Munich Office, Christoph Maurer, Head of Paris Office, and Bernd Uwe-Stucken, Head of the German desk in Shanghai.

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts